Atazanavir Concentration in Hair Is the Strongest Predictor of Outcomes on Antiretroviral Therapy

Factors predictive of virological failure on atazanavir in 310 HIV-infected patients

(2010) François-Xavier Lescure et al.   AIDS

Average Adherence to Boosted Protease Inhibitor Therapy, rather than the Pattern of Missed Doses, as a Predictor of HIV RNA Replication

(2010) Jean‐Jacques Parienti et al.   CLINICAL INFECTIOUS DISEASES

Rate of CD4+Cell Count Increase over Periods of Viral Load Suppression: Relationship with the Number of Previous Virological Failures

(2010) Maria Paola Trotta et al.   CLINICAL INFECTIOUS DISEASES

Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection

(2010) M Fabbiani et al.   HIV MEDICINE

Protease inhibitor levels in hair strongly predict virologic response to treatment

(2009) Monica Gandhi et al.   AIDS

Management of antiretroviral failure and resistance in developing countries

(2009) Claudia Hawkins et al.   Current Opinion in HIV and AIDS

“White Coat Compliance” Limits the Reliability of Therapeutic Drug Monitoring in HIV-1—Infected Patients

(2008) Thomas J. Podsadecki et al.   HIV CLINICAL TRIALS

Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry

(2008) Yong Huang et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY